Skip to Content
You are currently on the new version of our website. Access the old version .
  • 26 days
    Submission to First Decision
  • 7 days
    Acceptance to Publication

Journal of Genome Biotechnology and Genetics

Journal of Genome Biotechnology and Genetics is an international, peer-reviewed, open access journal on applied genome sciences, genome biotechnology and genetics published quarterly online by MDPI.
  • Open Access— free for readers, with article processing charges (APC) paid by authors or their institutions.
  • Rapid Publication: first decisions in 18 days; acceptance to publication in 7 days (median values for MDPI journals in the first half of 2026).
  • Recognition of Reviewers: Reviewers whose reports are timely and of high quality receive an APC discount voucher for a future publication in an MDPI journal. Become a reviewer.

Get Alerted

Add your email address to receive forthcoming issues of this journal.

All Articles (20)

  • Review
  • Open Access

CRISPR/Cas genome editing offers new opportunities for crop improvement, but its wider application remains limited more by the difficulty of delivering editing tools into plant cells and regenerating whole plants than by the editing chemistry itself. Many elite cereal, legume, and vegetatively propagated crops remain difficult to transform and regenerate, restricting genome editing to a limited range of amenable genotypes and often requiring additional breeding to introduce desired traits into elite varieties. This review examines how these interconnected barriers influence the recovery of fertile, heritably edited plants and evaluates emerging strategies to overcome them. We discuss developmental regulators such as BBM, WUS2, and GRF-GIF fusions, approaches that induce new meristems, and alternative delivery systems involving nanoparticles, viral vectors, pollen tubes, and DNA-free Cas ribonucleoproteins or guide RNAs. We distinguish the major steps from delivery and editing to plant regeneration, recovery of fertile plants, and transmission of the desired edits to progeny, highlighting that improvements in one step do not necessarily overcome the entire process. We compare these approaches in terms of their applicability across species and genotypes, reported efficiencies, heritability, and practical limitations. Persistent challenges include mosaicism, unintended off-target changes, and limited applicability to non-model and polyploid crops. Finally, we discuss how improved regeneration systems, base and prime editing, machine-learning-guided design, and evolving precision-breeding frameworks in the European Union, United States, Japan, and India may contribute to broader applications of genome editing in crop improvement.

Genome-editing technologies for crop improvement, from CRISPR nucleases to next-generation precision editors. (1) CRISPR/Cas9 uses a guide RNA (crRNA:tracrRNA, or a fused sgRNA) to direct the Cas9 nuclease to a target sequence adjacent to an NGG protospacer adjacent motif (PAM). It generates blunt double-strand breaks (DSBs) that are repaired by non-homologous end joining (NHEJ) or homology-directed repair (HDR). (2) CRISPR/Cas12a (Cpf1) is guided by a single crRNA, recognizes a T-rich (TTTV) PAM and produces staggered (sticky-end) DSBs that are also repaired by NHEJ or HDR. (3) CRISPR base editors fuse a catalytically impaired Cas9 (dCas9 or nCas9) to a cytidine or adenine deaminase, enabling single-base conversions (C-to-T or A-to-G) without DSBs. (4) CRISPR prime editors fuse a Cas9 nickase to a reverse transcriptase and use a prime editing guide RNA (pegRNA) to install precise edits without DSBs. Together, these tools enable targeted modification of genes controlling desirable agronomic traits, including higher yield, improved nutrition, disease resistance, abiotic stress tolerance, better quality and longer shelf life.
  • Article
  • Open Access

Hepatocellular carcinoma (HCC) remains a leading cause of cancer-related mortality, and obesity and type 2 diabetes (T2D) are recognized metabolic risk factors for its development. In this study, disease-associated gene lists for T2D and obesity were integrated with differentially expressed genes from the Cancer Genome Atlas Liver Hepatocellular Carcinoma cohort (TCGA-LIHC). Analysis of 371 primary HCC and 50 solid-tissue normal samples identified 2123 differentially expressed genes, including 715 upregulated and 1408 downregulated genes. The intersection of the 715 upregulated genes with 2055 T2D-associated and 1944 obesity-associated protein-coding genes identified 29 common candidates. Functional annotation identified 14 extracellular-region genes, which were evaluated using protein–protein interaction analysis and ranked using the maximal clique centrality algorithm. SPP1, encoding Osteopontin (OPN), was the highest-ranked candidate. SPP1 expression distinguished HCC from non-tumor tissues with an area under the receiver operating characteristic curve of 0.714 (95% confidence interval: 0.666–0.760). High SPP1 expression was associated with poorer overall survival, and continuous log2-transformed SPP1 expression remained independently associated with survival after adjustment for age, sex, and pathological stage. OPN was subsequently subjected to structural modeling, molecular dynamics simulation, B-cell epitope prediction, and the structure-guided optimization of anti-OPN monoclonal antibodies. Molecular docking and binding affinity analyses revealed that optimized mAbs exhibited predicted Kd values corresponding to approximately 10- to 650-fold stronger binding affinity and increased predicted hydrogen bonding at the interface. These findings support SPP1 as a promising immunotherapeutic target in metabolically driven HCC, warranting further experimental validation.

Integration of HCC, obesity, and type 2 diabetes gene sets and prioritization of extracellular candidates. (A) Three-way overlap between genes upregulated in TCGA-LIHC, obesity-associated protein-coding genes, and type 2 diabetes-associated protein-coding genes. Twenty-nine genes were shared among the three lists. (B) STRING protein–protein interaction network of the 14 common genes annotated to the extracellular region. CytoHubba analysis using the maximal clique centrality algorithm ranked SPP1 as the highest-scoring candidate.
  • Review
  • Open Access

Gut microbiome research turns sequencing reads into taxa and functions by matching them against a reference database of isolate and metagenome-assembled genomes. That database is the measuring instrument, yet its sensitivity is never reported. Reference incompleteness is therefore not a computational nuisance but a measurement bias; because the gaps are geographically structured, it behaves as differential misclassification rather than random error. The magnitudes are substantial. On identical data, the share of reads receiving a taxonomic assignment runs from 44% to 94.5% depending only on whether a standard Kraken2 database, UHGG, or a gut-specific catalog is used; missing genomes are enriched in non-Westernized populations. Formally, expected observed richness is true richness multiplied by population-specific coverage, so comparing two populations estimates the true ratio times the ratio of their coverages, a second term no study reports. In a simulation, a 5-percentage-point coverage gap raises the false-positive rate for a between-population richness comparison to 55%, a proof-of-concept rather than a real-world estimate. Reference bias distorts between-population comparisons in a determinate direction rather than simply blurring them and does so invisibly: batch correction leaves it untouched and quality control never sees it. We distinguish it from sampling bias, batch effects, and non-differential misclassification, and propose Minimum Information for Reference Reporting (MIRR).

A decade of catalog growth without a decade of provenance reporting. Principal human gut reference resources placed on a common timeline, with the scale of each release and, below, whether the publication reports per-country sample or genome contributions in an extractable form. Teal markers denote resources built wholly or partly from metagenome-assembled genomes; amber markers denote cultivation-based resources. Genome counts rose by roughly two orders of magnitude between 2016 and 2026, while machine-readable reporting of contributing countries appeared only at the end of that period. This figure is a schematic summary of published catalog characteristics. The horizontal axis denotes year of release and is not to scale. (Created in BioRender.com).
  • Article
  • Open Access

Lactic acid bacteria (LAB) are widely recognized for their antimicrobial activity and health-promoting effects. However, the genomic potential of underexplored species, such as Carnobacterium divergens, remains insufficiently characterized. This study aimed to perform a comprehensive genomic characterization of C. divergens UFJF 3.2, isolated from tilapia fillet, to identify functional and safety-related attributes supporting its probiotic potential. Whole-genome sequencing on the Illumina platform yielded a high-quality assembly (2.72 Mb) with 99.45% completeness and low contamination (0.55%). Taxonomic assignment was confirmed by ANIb (98.82%) and digital DNA–DNA hybridization (dDDH, 91.9%), supporting its classification within the species. Functional annotation identified 90 genes associated with probiotic-related traits, including coordinated stress response systems such as the complete arcABC operon (arginine deiminase pathway), dltABCD (cell wall modification), and the chaperone systems groESL and dnaK. In addition, genes associated with acid and bile tolerance, as well as exopolysaccharide biosynthesis and short-chain fatty acid (SCFA) production, were identified. Notably, a gene encoding a Zoocin A-like bacteriocin was identified in strain UFJF 3.2, a feature shared with only three other genomes within the species. Altogether, these genomic traits underscore the promising probiotic potential of C. divergens UFJF 3.2. This study provides a theoretical framework for future in vitro and in vivo investigations into its probiotic properties and prospective applications in food biotechnology.

Genome representation of Carnobacterium divergens UFJF 3.2. The green outer circle represents the reference genome (C. divergens GCA_900446755.1) The protein-coding sequences (CDSs) are shown in blue, tRNAs in pink, rRNAs in green, tmRNA in red, incomplete prophage in purple, and intact prophage in greenish-yellow. The gray arrows represent the genome contigs, and the GC content is shown in black.

Highly Accessed Articles

News & Conferences

Latest Issues

Open for Submission

Journal Sections

XFacebookLinkedIn
J. Genome Biotechnol. Genet. - ISSN 3042-8424